These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 24286590
1. High concentration capsaicin for treatment of peripheral neuropathic pain: effect on somatosensory symptoms and identification of treatment responders. Höper J, Helfert S, Heskamp ML, Maihöfner CG, Baron R. Curr Med Res Opin; 2014 Apr; 30(4):565-74. PubMed ID: 24286590 [Abstract] [Full Text] [Related]
2. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study. Mankowski C, Poole CD, Ernault E, Thomas R, Berni E, Currie CJ, Treadwell C, Calvo JI, Plastira C, Zafeiropoulou E, Odeyemi I. BMC Neurol; 2017 Apr 21; 17(1):80. PubMed ID: 28431564 [Abstract] [Full Text] [Related]
4. The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis. Wagner T, Poole C, Roth-Daniek A. Pain Med; 2013 Aug 21; 14(8):1202-11. PubMed ID: 23710678 [Abstract] [Full Text] [Related]
5. Treatment of painful radiculopathies with capsaicin 8% cutaneous patch. Baron R, Treede RD, Birklein F, Cegla T, Freynhagen R, Heskamp ML, Kern KU, Maier C, Rolke R, Seddigh S, Sommer C, Ständer S, Maihöfner C. Curr Med Res Opin; 2017 Aug 21; 33(8):1401-1411. PubMed ID: 28436279 [Abstract] [Full Text] [Related]
6. Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study. Maihofner C, Heskamp ML. Curr Med Res Opin; 2013 Jun 21; 29(6):673-83. PubMed ID: 23551064 [Abstract] [Full Text] [Related]
7. Capsaicin 8 % as a cutaneous patch (Qutenza™): analgesic effect on patients with peripheral neuropathic pain. Raber JM, Reichelt D, Grüneberg-Oelker U, Philipp K, Stubbe-Dräger B, Husstedt IW. Acta Neurol Belg; 2015 Sep 21; 115(3):335-43. PubMed ID: 25421590 [Abstract] [Full Text] [Related]
8. Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain. Treede RD, Wagner T, Kern KU, Husstedt IW, Arendt G, Birklein F, Cegla T, Freynhagen R, Gockel HH, Heskamp ML, Jager H, Joppich R, Maier C, Leffler A, Nagelein HH, Rolke R, Seddigh S, Sommer C, Stander S, Wasner G, Baron R. Curr Med Res Opin; 2013 May 21; 29(5):527-38. PubMed ID: 23444968 [Abstract] [Full Text] [Related]
9. Effectiveness and Impact of Capsaicin 8% Patch on Quality of Life in Patients with Lumbosacral Pain: An Open-label Study. Zis P, Bernali N, Argira E, Siafaka I, Vadalouka A. Pain Physician; 2016 May 21; 19(7):E1049-53. PubMed ID: 27676676 [Abstract] [Full Text] [Related]
10. Ipsilateral and contralateral sensory changes in healthy subjects after experimentally induced concomitant sensitization and hypoesthesia. Enax-Krumova EK, Pohl S, Westermann A, Maier C. BMC Neurol; 2017 Mar 23; 17(1):60. PubMed ID: 28335745 [Abstract] [Full Text] [Related]
11. The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study. Aitken E, McColl G, Kingsmore D. Pain Med; 2017 Feb 01; 18(2):330-340. PubMed ID: 28204726 [Abstract] [Full Text] [Related]
12. Capsaicin. Neuropathic pain: playing with fire... Prescrire Int; 2010 Aug 01; 19(108):153-5. PubMed ID: 20939441 [Abstract] [Full Text] [Related]
13. Application of the capsaicin 8% cutaneous patch in neuropathic pain of the head and face: A case series. Gaul C, Resch S. Cephalalgia; 2015 May 01; 35(6):545-50. PubMed ID: 25217483 [Abstract] [Full Text] [Related]
14. Use of High-Concentration Capsaicin Patch for the Treatment of Pelvic Pain: Observational Study of 60 Inpatients. Levesque A, Riant T, Labat JJ, Ploteau S. Pain Physician; 2017 May 01; 20(1):E161-E167. PubMed ID: 28072808 [Abstract] [Full Text] [Related]